Literature DB >> 26693037

Association of Ophthalmologic Disorders and Depression in the Elderly: A Review of the Literature.

Scott McCusker1, Maju Mathew Koola1.   

Abstract

OBJECTIVE: To review the prevalence of depression in common ophthalmologic disorders in the elderly and provide insight into treatment. DATA SOURCES: PubMed, Google Scholar, and DynaMed were searched using the terms depression and ophthalmology in combination with depression, mood disorders, cataracts, vision loss, age-related macular degeneration, primary open-angle glaucoma, and Fuchs corneal dystrophy. Articles were limited to those published in the English language between 1993 and 2013. STUDY SELECTION AND DATA EXTRACTION: Twenty-eight articles that studied the prevalence of depression in ophthalmologic disorders were screened and summarized.
RESULTS: The strongest association between ophthalmologic disorders and psychiatry is depression. In the future, primary care physicians and psychiatrists should play a significant role in the assessment and treatment of depression in visually impaired patients.
CONCLUSION: Greater recognition and treatment of depression in individuals with impaired vision is warranted.

Entities:  

Year:  2015        PMID: 26693037      PMCID: PMC4664565          DOI: 10.4088/PCC.14r01731

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


  27 in total

1.  Depression and anxiety in visually impaired older people.

Authors:  Jennifer R Evans; Astrid E Fletcher; Richard P L Wormald
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

2.  Depression and disability associated with impaired vision: the MoVies Project.

Authors:  B W Rovner; M Ganguli
Journal:  J Am Geriatr Soc       Date:  1998-05       Impact factor: 5.562

3.  Prevalence of depression among older Americans: the Aging, Demographics and Memory Study.

Authors:  David C Steffens; Gwenith G Fisher; Kenneth M Langa; Guy G Potter; Brenda L Plassman
Journal:  Int Psychogeriatr       Date:  2009-06-12       Impact factor: 3.878

4.  Topical beta-blockers are not associated with an increased risk of treatment for depression.

Authors:  Igor Kaiserman; Nadia Kaiserman; Asher Elhayany; Shlomo Vinker
Journal:  Ophthalmology       Date:  2006-07       Impact factor: 12.079

5.  Models of open-angle glaucoma prevalence and incidence in the United States.

Authors:  H A Quigley; S Vitale
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

6.  Explaining the relationship between three eye diseases and depressive symptoms in older adults.

Authors:  Mihaela L Popescu; Hélène Boisjoly; Heidi Schmaltz; Marie-Jeanne Kergoat; Jacqueline Rousseau; Solmaz Moghadaszadeh; Fawzia Djafari; Ellen E Freeman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

7.  Depression in patients with glaucoma as measured by self-report surveys.

Authors:  M Roy Wilson; Anne L Coleman; Fei Yu; Irene Fong Sasaki; Eric G Bing; Matthew H Kim
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

8.  Vision-specific distress and depressive symptoms in people with vision impairment.

Authors:  Gwyneth Rees; Hui Wen Tee; Manjula Marella; Eva Fenwick; Mohamed Dirani; Ecosse L Lamoureux
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

9.  Sensory impairment and quality of life in a community elderly population.

Authors:  C Carabellese; I Appollonio; R Rozzini; A Bianchetti; G B Frisoni; L Frattola; M Trabucchi
Journal:  J Am Geriatr Soc       Date:  1993-04       Impact factor: 5.562

10.  Psychosocial impact of visual impairment in working-age adults.

Authors:  S R Nyman; M A Gosney; C R Victor
Journal:  Br J Ophthalmol       Date:  2009-10-22       Impact factor: 4.638

View more
  8 in total

Review 1.  LncRNAs in ocular neovascularizations.

Authors:  Yacouba Cissé; Lang Bai; Min-Ting Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Combined Vision and Hearing Difficulties Results in Higher Levels of Depression and Chronic Anxiety: Data From a Large Sample of Spanish Adults.

Authors:  Shahina Pardhan; Lee Smith; Rupert Bourne; Adrian Davis; Nicolas Leveziel; Louis Jacob; Ai Koyanagi; Guillermo F López-Sánchez
Journal:  Front Psychol       Date:  2021-01-18

3.  A Framework for Automating Psychiatric Distress Screening in Ophthalmology Clinics Using an EHR-Derived AI Algorithm.

Authors:  Samuel I Berchuck; Alessandro A Jammal; David Page; Tamara J Somers; Felipe A Medeiros
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

4.  Geographic variation in cumulative incidence of private cataract surgery in Australia and its influencing factors: Findings from the 45 and Up Study.

Authors:  Zhuoting Zhu; Liying Li; Jane Scheetz; Wei Wang; Xianwen Shang; Lei Zhang; Mingguang He
Journal:  Eye (Lond)       Date:  2021-08-09       Impact factor: 4.456

Review 5.  Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases.

Authors:  Fang Li; Xuyang Wen; He Zhang; Xianqun Fan
Journal:  Int J Mol Sci       Date:  2016-03-31       Impact factor: 5.923

6.  Mastery and self-esteem mediate the association between visual acuity and mental health: a population-based longitudinal cohort study.

Authors:  I M Maaswinkel; H P A van der Aa; G H M B van Rens; A T F Beekman; J W R Twisk; R M A van Nispen
Journal:  BMC Psychiatry       Date:  2020-09-24       Impact factor: 3.630

7.  Gender Differences in the Association Between Cataract and Mental Health in Adults With Diabetes: A Cross-Sectional Analysis From the Spanish National Health Survey 2017.

Authors:  Guillermo F López Sánchez; Lee Smith; Louis Jacob; Jae Il Shin; Ai Koyanagi; Shahina Pardhan
Journal:  Front Public Health       Date:  2021-12-07

8.  Gender Differences in the Association between Physical Inactivity and Mental-Health Conditions in People with Vision or Hearing Impairment.

Authors:  Guillermo F López-Sánchez; Lee Smith; Rubén López-Bueno; Shahina Pardhan
Journal:  Int J Environ Res Public Health       Date:  2022-03-11       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.